Loading insider details...
Latest Form 4 (Jun 9, 2026): Sale of 1,322 XENE shares, $70.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 1,322 | $70.3K |
| Jun 4, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 2,645 | n/a |
| Jun 6, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 17,012 | n/a |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 3,500 | $25.8K |
| Jun 5, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 15,542 | n/a |
| Dec 15, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 6,378 | $62.8K |
| Jun 2, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,475 | n/a |
| Nov 28, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 2,057 | $70.6K |
| Jun 29, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 18,000 | n/a |
| Dec 10, 2021 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 2,057 | $7.5K |